Konstantin Ermolenko

Dr. Konstantin Ermolenko

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
MKMarina Kotyleva
Marina Kotyleva
AKAnna Kotrova
Anna Kotrova
STSergey Tichonov
Sergey Tichonov
НNНадежда Novikova
Надежда Novikova
SASuvorov N Alexander
Suvorov N Alexander
The features of gut microbiota in metabolic syndrome (MS) and ways to correct it using autoprobiotics, based on indigenous bacteria obtained from fecal samples of the host, remain unexplored. The aim of the study was to investigate the effectiveness of an indigenous consortium (IC) of fecal bacteria in treatment of patients with MS. The study was carried out on 36 patients with MS, manifested with abdominal obesity, eating disorders, dyslipidemia, and hypertension. The control group was formed by 20 healthy volunteers. Samples of IC and gut microbiota content were examined by qPCR and metagenome (16S rRNA) analysis before and after therapy. The decrease in anthropometric parameters of obesity, liver enzyme level correction, reduction in C reactive protein and triglyceride concentrations were revealed after IC usage. The decrease in genera Bifidobacterium, Enterobacter, Paraprevotella, and Prevotella, as well as an increase in Bacteroides fragilis and Oscillospira spp. populations were shown after consumption of IC. A negative correlation between the quantity of B. fragilis and the anthropometric parameters of obesity (r = −0.48) and C reactive protein level (r = −0.36) in serum was established. Thus, IC can be considered as a potential functional personified product for the therapy of MS.

1 April 2023 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
NGN. V. Gonchar
N. V. Gonchar
AKA. K. Kopersak
A. K. Kopersak
NSN. V. Skripchenko
N. V. Skripchenko
AKA. S. Kvetnaya
A. S. Kvetnaya
AMA. M. Moskalyuk
A. M. Moskalyuk
SGS. G. Grigor'EV
S. G. Grigor'EV
Резистентность к антибактериальным препаратам и бактериофагам изолятов Klebsiella pneumoniae , выделенных от детей разного возраста с кишечными инфекциями

29 October 2019 in Pharmateca
Verified
Journal Article
Closed access
KEK.D. Ermolenko Ermolenko
K.D. Ermolenko Ermolenko
EME.A. Martens Martens
E.A. Martens Martens
NBN.P. Boldyreva Boldyreva
N.P. Boldyreva Boldyreva
KEKonstantin Ermolenko
Konstantin Ermolenko

31 March 2023 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
KEKonstantin Ermolenko
Konstantin Ermolenko
Возможности прогнозирования неблагоприятных исходов кампилобактериоза у детей

1 January 2025 in Infectious diseases: News, Opinions, Training
Verified
Journal Article
Open access
MAM.V. Alagova
M.V. Alagova
IRI.V. Razdyakonova
I.V. Razdyakonova
ISI.G. Samoylova
I.G. Samoylova
KEKonstantin Ermolenko
Konstantin Ermolenko
OSOksana Svitich
Oksana Svitich
ARA.K. Ratnikova
A.K. Ratnikova
Эффективность средств патогенетической терапии при ротавирусной инфекции у детей

14 December 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
KEKonstantin Ermolenko
Konstantin Ermolenko
NGN.V. Gonchar
N.V. Gonchar
NSN.V. Skripchenko
N.V. Skripchenko
Objective of the research: to analyze clinical and laboratory manifestations of COVID-19 with a predominant lesion of the gastrointestinal tract (GIT) in children. It was revealed that incidence of this form of COVID-19 in children is underestimated. Based on the analysis of literature data and original clinical observations, the article describes current ideas about the frequency of detecting the form of COVID-19 with a predominant lesion of the GIT, its clinical and laboratory characteristics, the mechanisms of infectious process development in the digestive organs and approaches to rational laboratory diagnostics. The feasibility of PCR in feces in patients with suspected COVID-19 is confirmed. A description of a clinical case of COVID-19 severe form, which required differential diagnosis with acute bacterial gastroenterocolitis, is presented.